Background-Magnetic resonance spectroscopy can quantify myocardial triglyceride content in type 2 diabetic patients.
T he pathogenic mechanisms underlying diabetic heart disease are likely to be multifactorial, ranging from altered myocardial metabolism to endothelial dysfunction, microvascular disease, autonomic neuropathy, and altered myocardial structure with fibrosis. 1 Increasing evidence is emerging on the role of altered myocardial metabolism with subsequent lipotoxic injury from lipid oversupply. Recent studies have evaluated the role of myocardial triglyceride accumulation (steatosis) and diastolic dysfunction in patients with type 2 diabetes mellitus. 2, 3 Although differences in transmitral flow patterns indicative of diastolic dysfunction were seen in diabetics compared with normal control subjects, there was no significant difference in global systolic function as determined by ejection fraction (EF). 2, 3 In contrast, strain imaging and strain rate (SR) imaging are more sensitive indexes of myocardial function and have been shown to be impaired in diabetic patients. 4 -10 However, no studies to date have evaluated the relationship between myocar-dial triglyceride content and both left (LV) and right ventricular (RV) myocardial functions. Therefore, the aim of the present study was to relate myocardial triglyceride content as determined by magnetic resonance (MR) spectroscopy with biventricular myocardial strain and SR as determined by echocardiographic 2-dimensional (2D) speckle tracking analysis.
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Methods
Patient Sample
The original Pioglitazone Influence on Triglyceride Accumulation in the Myocardium in Diabetes (PIRAMID) trial included a total of 78 diabetic patients recruited from 2 centers (Leiden University Medical Center, Leiden, and VU University Medical Center, Amsterdam, the Netherlands). 11 The present study included only 42 diabetic patients who underwent a comprehensive MR (including spectroscopy) and echocardiographic examination at baseline from a single center (Leiden University Medical Center).
The inclusion and exclusion criteria have previously been reported. 11 Briefly, only male diabetics were recruited to avoid possible confounding influences of female gender and plasma estrogen levels on lipid metabolism and myocardial triglyceride accumulation. Inclusion criteria included type 2 diabetes mellitus diagnosed according to World Health Organization criteria 12 and treated with sulfonylurea derivatives in stable doses, glycohemoglobin level between 6.5% and 8.5%, and resting blood pressure Ͻ150/85 mm Hg with or without antihypertensive medication. In addition, as an inclusion criterion, the presence of myocardial ischemia was excluded in all patients by a negative high-dose dobutamine stress echocardiogram. 3 Exclusion criteria included known cardiovascular disease or diabetes-related complications, including proliferative retinopathy, autonomic neuropathy as excluded by Ewing tests, 13 and microalbuminuria as excluded by measurements of albumin-to-creatinine ratio in a urine sample.
Study Protocol
All patients underwent MR imaging (MRI) examinations with MR spectroscopy and transthoracic echocardiography at baseline. Both LV and RV volumes and EFs were quantified by MRI, whereas LV and RV myocardial strain and SR were quantified by echocardiographic 2D speckle tracking analyses. The myocardial triglyceride content was measured by MR spectroscopy, and the study sample was then dichotomized into 2 groups based on the median value. Biventricular volumes, EF, and myocardial strain/SR were then compared between the 2 groups, and independent correlates of LV and RV myocardial functions were identified.
Cardiac MRI Protocol
All patients underwent MRI examinations for assessment of biventricular volumes and functions and myocardial triglyceride content after an overnight fast with a 1.5-T whole-body MR scanner (Gyroscan ACS/NT15; Philips, Best, the Netherlands). During the examinations, the entire heart was imaged in the short-axis orientation with ECG-gated breath-hold-balanced steady-state freeprecession imaging. Imaging parameters included the following: echo time, 1.7 milliseconds; repetition time, 3.4 milliseconds; flip angle, 35°; slice thickness, 10 mm with a gap of 0 mm; field of view, 400ϫ400 mm; and reconstructed matrix size, 256ϫ256.
LV and RV end-diastolic volume index and end-systolic volume index were measured and corrected for body surface area. 14 LVEF and RVEF were then calculated and expressed as percentages. LV mass (excluding papillary muscles) was also measured and indexed to body surface area. LV mass-cavity ratio (which is conceptually similar to relative wall thickness) was calculated as previously described, with a higher mass-cavity ratio indicating increasing relative wall thickness. 15 All images were digitally stored on hard disks and analyzed offline with dedicated quantitative software (MASS, Medis, Leiden, the Netherlands).
Cardiac Proton MR Spectroscopy
Cardiac proton MR spectroscopy ([1H]-MRS) was performed as previously described. 16 Briefly, myocardial [1H]-MRS spectra were obtained from the interventricular septum to avoid contamination from epicardial fat. Spectroscopic data acquisitions were doubletriggered with ECG triggering and respiratory navigator echoes to minimize motion artifacts. Water-suppressed spectra were acquired to measure myocardial triglyceride content, and spectra without water suppression were acquired and used as an internal standard. 16 [1H]-MRS data were fitted by use of Java-based MR user interface software (jMRUI version 2.2, Leuven, Belgium) as previously described. 16 Myocardial triglyceride content relative to water was calculated and expressed as a percentage based on the following: signal amplitude of triglyceride divided by signal amplitude of waterϫ100. 16 
Echocardiography
Transthoracic echocardiography was performed with the subjects at rest using commercially available ultrasound transducer and equipment (M3S probe, Vivid 7, GE-Vingmed, Horten, Norway). All images were digitally stored on hard disks for offline analysis (EchoPAC version 108.1.5, GE-Vingmed). A complete 2D, color, pulsed, and continuous-wave Doppler echocardiogram was performed according to standard techniques. 17, 18 Evaluation of the traditional parameters of LV diastolic function was performed by assessing transmitral inflow and pulmonary venous velocities using conventional pulsed-wave Doppler echocardiography in the apical 4-chamber view with a 2-mm sample volume. Transmitral early (E-wave) and late (A-wave) diastolic velocities and deceleration time were recorded at the mitral leaflet tips. LV isovolumic relaxation time was also recorded. The pulmonary venous peak systolic and diastolic velocities were recorded with the sample volume positioned 1 cm below the orifice of the right superior pulmonary vein in the left atrium.
Two-Dimensional Speckle Tracking
We performed 2D speckle tracking analyses on standard echocardiographic gray-scale images. LV longitudinal function was determined from the 3 apical (2-, 3-, and 4-chamber) views, whereas the RV free wall longitudinal function was determined from the apical 4-chamber view only (the Figure) . During analysis, the endocardial border was manually traced at end systole, and the region of interest width was adjusted to include the entire myocardium. The software then automatically tracks and accepts segments of good tracking quality and rejects poorly tracked segments while allowing the observer to manually override its decisions on the basis of visual assessments of tracking quality. Peak longitudinal strain, peak systolic SR, and peak early diastolic SR for both the LV and RV myocardium were determined. We calculated mean LV global longitudinal strain/SR from the 3 individual apical global longitudinal strain/SR curves and obtained RV free wall longitudinal strain/SR from the apical 4-chamber view. All strain and SR measurements were exported to a spreadsheet (Microsoft Excel 2002, Microsoft Corp, Redmond, Wash).
Previous work has reported the intraobserver and interobserver variabilities in our laboratory as expressed by mean absolute difference for longitudinal strain (1.2Ϯ0.5% and 0.9Ϯ1.0%), systolic SR (0.10Ϯ0.06 and 0.09Ϯ0.08 second Ϫ1 ), and early diastolic SR (0.08Ϯ0.05 and 0.13Ϯ0.09 second Ϫ1 ). 10 The study was approved by the local institutional ethics committee. Written informed consent was obtained from all patients.
Statistical Analysis
Because of the relatively small number of patients, all continuous variables were presented as median and 25th and 75th percentiles. The Mann-Whitney U test was used to compare 2 groups of unpaired data. Multivariable linear regression analysis was used to identify independent correlates of LV and RV strain/SR. To generate the multivariable models, univariate variables with a value of PՅ0.20 were entered as covariates. To avoid multicollinearity between the univariate correlates, a tolerance level of Ͼ0.5 (corresponding to a correlation coefficient of Ͼ0.7) was set. A 2-tailed value of PϽ0.05 was considered significant. All statistical analyses were performed with SPSS for Windows, version 17 (SPSS Inc, Chicago, Ill).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
The median age was 59 years (25th and 75th percentiles, 54 and 62 years), and the median diabetes diagnosis duration was 4 years (range, 1 to 11 years). The mean myocardial triglyceride content was 0.78Ϯ0.42%. When the study sample was dichotomized on the basis of the median myocardial triglyceride level of 0.76%, there were no significant differences in blood glucose level, glycohemoglobin levels, and lipid profiles between the 2 groups (Table 1) . However, patients with higher myocardial triglyceride content had greater impairment of global LV longitudinal strain and SR (Table 2) .
LV Volumes and Functions
To identify the independent correlates of global LV longitudinal strain and SR, univariate correlates with a value of PՅ0.20 (age, systolic blood pressure, fasting blood glucose level, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and myocardial triglyceride content) were all entered into multiple linear regression models. Total cholesterol was not included in the model because of high collinearity with low-density lipoprotein cholesterol. Table 3 shows that the myocardial triglyceride content measured by MR spectroscopy was an independent correlate of global LV longitudinal strain, systolic SR, and diastolic SR. Table 2 summarizes the RV volumes, EFs, free wall longitudinal strain, and SR. Similarly, there were no significant differences in MRI-derived RV volumes and EFs between the Figure. Graphic example of the speckle tracking analyses to derive LV and RV ventricular myocardial strain and SR measurements. Mean LV global longitudinal strain/SR was calculated from the 3 individual (4-, 2-, and 3-chamber) strain/SR curves, whereas the RV free wall strain/SR was derived from the 4-chamber view only. The mean global LV longitudinal strain, systolic SR, and diastolic SR were Ϫ16.6%, Ϫ0.85 s Ϫ1 , and 1.01 s Ϫ1 , respectively. The mean RV free wall longitudinal strain, systolic SR, and diastolic SR were Ϫ29.0%, Ϫ1.30 s Ϫ1 , and 1.31 s Ϫ1 , respectively.
RV Volumes and Functions
2 groups of patients. However, patients with higher myocardial triglyceride content had greater impairment of RV free wall longitudinal strain and SR.
To identify independent correlates of RV free wall longitudinal strain and SR, age, fasting blood glucose level, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and myocardial triglyceride content were all entered into the multiple linear regression models. Table 4 shows that myocardial triglyceride content was an independent correlate of RV free wall longitudinal strain, systolic SR, and diastolic SR.
Discussion
In the present study, MRI assessment revealed similar LV/RV volumes and EFs in type 2 diabetic patients with high versus low myocardial triglyceride content as measured by MR spectroscopy. However, 2D speckle tracking deformation imaging demonstrated greater impairments of biventricular strain/SR in patients with higher myocardial triglyceride content. Myocardial triglyceride content was an independent correlate of LV and RV longitudinal strain, systolic SR, and diastolic SR. 
Myocardial Substrate Metabolism and Steatosis
The origin of diabetic heart disease is complex and multifactorial, ranging from altered myocardial metabolism to upregulation of the renin-angiotensin system, increased oxidative stress, endothelial dysfunction with microvascular disease, autonomic neuropathy, and altered myocardial structure with fibrosis. 1 However, recent evidence suggests the role of myocardial lipotoxic injury from lipid oversupply in contributing to diabetic heart disease. 19 Under normal physiological conditions, fatty acids are absorbed through the intestines and stored as triglycerides within adipocytes with minimal accumulation within nonadipose tissues such as the heart. However, the combination of diabetes mellitus and its metabolic derangements, insulin resistance, visceral adiposity, and increased dietary fatty acid intake leads to increased myocardial fatty acid delivery and uptake. This results in the accumulation of intracellular triglycerides within the myocyte cytoplasm (also known as steatosis). 19 -22 However, part of the excess fatty acid is redirected into nonoxidative pathways, giving rise to toxic fatty acid intermediates such as ceramide. These toxic fatty acid intermediates disrupt normal cellular signaling, leading to mitochondrial dysfunction, cellular damage, apoptosis, and eventual replacement fibrosis and myocardial contractile dysfunction. Thus, although it is currently accepted that intracellular triglycerides are probably inert, the intracellular concentration is reflective of an increased concentration of toxic fatty acid intermediates. Therefore, the observed relationship between intracellular triglyceride accumulation and myocardial dysfunction likely represents an association mediated by the accumulation of toxic intermediates from increased nonoxidative fatty acid metabolism. Although animal studies have shown an association between myocardial triglyceride accumulation, eccentric LV hypertrophy, and systolic dysfunction, 23 human studies showing similar association between myocardial steatosis and myocardial dysfunction have been limited.
Myocardial Steatosis and Myocardial Dysfunction
Several studies have examined the relationship between myocardial triglyceride accumulation and LV function. 2, 3 McGavock and coworkers showed that there was no association between myocardial triglyceride accumulation and LV diastolic function. 2 However, their results could be confounded by their inclusion of a heterogeneous group of diabetic patients and the use of insulin (a lipogenic agent). 2 In contrast, Rijzewijk and coworkers were able to demonstrate diastolic dysfunction in a group of uncomplicated diabetic patients with myocardial steatosis compared with healthy control subjects. 3 However, both groups could not demonstrate a correlation between myocardial triglyceride content and LVEF. 2, 3 Thus, these diabetic patients have traditionally been labeled as having diastolic dysfunction with normal systolic function. However, this is largely a misnomer because of the insensitivity of conventional systolic parameters such as LVEF in identifying subtle changes in myocardial contractility. 24 In contrast, 2D speckle tracking-derived myocardial strain and SR indexes are more sensitive in detecting subclinical myocardial dysfunction and have been shown to be impaired in diabetic patients compared with normal control subjects. 4, 8, 10 To date, no studies have related myocardial strain and SR analyses by echocardiography to myocardial triglyceride accumulation. In the present study, MRI-derived LV volumes and EFs were similar between patients with high and those with low myocardial triglyceride levels. However, this study is first to demonstrate that patients with high myocardial triglyceride levels have significantly greater impairment of LV myocardial longitudinal strain, systolic SR, and diastolic SR. Furthermore, because the diabetic metabolic derangements with subsequent myocardial steatosis should hypothetically have a similar adverse effect on the RV, the present study also demonstrates RV free wall myocardial systolic and diastolic dysfunctions in patients with high myocardial triglyceride levels. The present study is first to demonstrate an independent association between myocardial triglyceride accumulation in diabetic patients and biventricular myocardial dysfunctions. However, intracellular surplus triglyceride itself is likely to be relatively inert, whereas the lipid intermediates derived from nonoxidative pathways are probably responsible for lipotoxic injury and eventual cellular apoptosis. 20 Thus, the observed relationship between myocardial triglyceride accumulation and myocardial dysfunction is probably an association secondary to the adverse diabetic metabolic profile rather than a causal relationship.
Clinical Implications
The novel aspect of the present study is the demonstration of the independent association between myocardial triglyceride content and biventricular myocardial systolic and diastolic functions. In animal studies, therapeutic interventions aiming at reducing myocardial triglyceride accumulation have demonstrated beneficial myocardial effects. 23 Thus, future human studies assessing the effectiveness of antisteatotic therapy in type 2 diabetics may include quantifications of myocardial triglyceride content by spectroscopy and assessments of myocardial functions by strain/SR imaging on 2D speckle tracking echocardiography.
Study Limitations
This was a relatively small study, and several characteristics such as LV and RV volumes were not statistically different between patients with high and those with low myocardial triglyceride content. Thus, future studies should include more patients to avoid possible type 1 error.
Conclusions
Uncomplicated type 2 diabetic patients with high levels of myocardial triglyceride content and no ischemia showed greater impairments of biventricular myocardial strain and SR but biventricular volumes and EFs similar to those of patients with low levels of myocardial triglyceride. Myocardial triglyceride accumulation was an independent correlate of biventricular myocardial strain and SR.
